Cite
HARVARD Citation
Waterhouse, D. et al. (2011). Lipid-based nanoformulation of irinotecan: dual mechanism of action allows for combination chemo/angiogenic therapy. Nanomedicine. pp. 1645-1654. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Waterhouse, D. et al. (2011). Lipid-based nanoformulation of irinotecan: dual mechanism of action allows for combination chemo/angiogenic therapy. Nanomedicine. pp. 1645-1654. [Online].